About Us Harmattan AI is a next-generation defense prime building autonomous and scalable defense systems. Following the close of a $200M Series B, valuing the company at $1.4 billion, we are expanding our teams and capabilities
// Your mission Eligo is building a pioneering platform technology that enables us to engineer phage-derived particles (Eligobiotics) to package and deliver modular therapeutic DNA payloads to genetically (re)program a wide range of bacterial species in